Hepatocyte proliferation and serum hepatocyte growth factor levels in patients with alcoholic hepatitis

Journal of Hepatology

Volumn 24, Issue 4, 1996, Pages 385-390

  Hillan, Kenneth J ^a,c   Logan, Martin C ^a   Ferrier, Rod K ^a   Bird, George L A ^b   Bennett, Gregory L ^c   McKay, Ian C ^d   MacSween, Roderick N M ^a  

^a WESTERN INFIRMARY   (United Kingdom)

^b GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^c GENENTECH INC   (United States)

^d Genentech Inc ^*

Author keywords

Alcohol; Hepatitis; Hepatocyte growth factor

Indexed keywords

CD30 ANTIGEN; SCATTER FACTOR;

ADULT; AGED; ALCOHOL LIVER DISEASE; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; FEMALE; HUMAN; LIVER BIOPSY; LIVER CELL; MALE; PRIORITY JOURNAL;

EID: 0029990117     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80157-7     Document Type: Article

References (22)

1. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, Tashiro K, Shimizu S. Molecular-cloning and expression of human hepatocyte growth-factor. Nature 1989; 342: 440-3.
2. Bottaro DP, Rubin JS, Faletto DL, Chan AM, Kmiecik TE, Vande Woude GF, Aaronson SA. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991; 251: 802-4.
3. Sugiyama H, Sugihara J, Murakami N, Koshino Y, Moriwaki H, Muto Y. Clinical significance of determination of human hepatocyte growth factor (hHGF) in sera from patients with severe hepatitis. Acta Hepatol Jpn 1993; 34: 493-503.
4. Ishiki Y, Ohnishi H, Muto Y, Matsumoto K, Nakamura T. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatology 1992; 16: 1227-35.
5. Roos F, Terrell TG, Godowski PJ, Chamow SM, Schwall RH. Reduction of α-naphthylisothiocyanate-induced hepatotoxicity by recombinant human hepatocyte growth factor. Endocrinology 1992; 131: 2540-4.
6. Fujiwara K, Nagoshi S, Ohno A, Hirata K, Ohata Y, Mochida S, Tomiya T, Higashio K, Kurokawa K. Stimulation of liver growth by exogenous human hepatocyte growth factor in normal and partially hepatectomized rats. Hepatology 1993; 18: 1443-9.
7. Tsubouchi H, Kawakami S, Hirono S, Miyazaki H, Kimoto M, Arima T, Sekiyama K, Yoshiba M, Arakaki N, Daikuhara Y. Prediction of outcome in fulminant hepatic failure by serum human hepatocyte growth factor. Lancet 1992; 340: 307.
8. Gerdes J, Becker MHG, Key G, Cattoretti G. Immunohistochemical detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues. J Pathol 1992; 168: 85-6.
9. Lokker NA, Mark MR, Luis EA, et al. Structure-function analysis of hepatocyte growth factor: identification of variants that lack mitogenic activity yet retain high affinity receptor binding. EMBO J 1992; 11: 2503-10.
10. Mizuno K, Inoue H, Hagiya, Shimizu S, Nose T, Shimohigashi Y, Nakamura T. Hairpin loop and second kringle domain are essential sites for heparin binding and biological activity of hepatocyte growth factor. J Biol Chem 1994; 269: 1131-6.
11. Lokker NA, Presta LG, Godowski PJ. Mutational analyses and molecular modelling of the N-terminal kringle-containing domain of hepatocyte growth factor identifies amino acid side chains important for interactions with the c-Met receptor. Prot Eng 1994; 7: 895-903.
12. Matsumoto K, Takehara T, Inoue H, Hagiya M, Shimizu S, Nakamura T. Deletion of kringle domains or the N-terminal hairpin structure in hepatocyte growth factor results in marked decreases in related biological activities. Biochem Biophys Res Commun 1991; 181: 691-9.
13. Matsumoto K, Nakamura T. Molecular structure, roles in liver regeneration, and other biological functions. Critical Reviews in Oncogenesis 1992; 3: 27-54.
14. Shiota G, Wang TC, Nakamura T, Schmidt EV. Hepatocyte growth factor in transgenic mice: effects on hepatocyte growth, liver regeneration and gene expression. Hepatology 1994; 19: 962-72.
15. Tomiya T, Nagoshi S, Fujiwara K. Significance of serum human hepatocyte growth factor levels in patients with hepatic failure. Hepatology 1992; 15: 1-4.
16. Tsubouchi H, Niitani Y, Hirmo ST, Nakayama H, Gohda E, Arakaki N, Sakiyama O, Takahashi K, Kimoto M, Kawakami S. Levels of human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assay. Hepatology 1991; 13: 1-5.
17. Tomiya T, Tani M, Yamada S, Hayashi S, Umeda N, Fujiwara K. Serum hepatocyte growth factor levels in hepatectomized and non-hepatectomized surgical patients. Gastroenterology 1992; 103: 1621-4.
18. Appasamy R, Tanabe M, Murase N, Zarnegar R, Vanthiel DH, Ventkataramanan R, Michalopoulos GM. Hepatocyte growth factor, blood clearance, organ uptake and biliary excretion in normal and partially hepatectomized rats. Lab Invest 1993; 68: 270-6.
19. Zioncheck TF, Richardson L, DeGuzman GG, Modi NB, Hansen SE, Godowski PJ. The pharmacokinetics, tissue localisation and metabolic processing of recombinant human hepatocyte growth factor after intravenous administration in rats. Endocrinology 1994; 134: 1879-87.
20. Rose DSC, Maddox PH, Brown DC. Which proliferation markers for routine immunohistology? A comparison of five antibodies. J Clin Pathol 1994; 47: 1010-4.
21. Carter EA, Wands JR. Ethanol inhibits hormone stimulated hepatocyte DNA synthesis. Biochem Biophys Res Commun 1985; 128: 767-74.
22. Fang JWS, Bird GLA, Nakamura T, Davis GL, Lau JYN. Hepatocyte proliferative response as a prognostic marker in acute alcoholic hepatitis. Lancet 1994; 343: 820-4.